These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 37165643)

  • 1. Efficacy of zinc supplementation for the treatment of dysmenorrhoea: a double-blind randomised controlled trial.
    Obiagwu HI; Eleje GU; Obiechina NJA; Nwosu BO; Udigwe GO; Ikechebelu JI; Ugboaja JO; Okoro CC; Okonkwo IO; Okwuosa AO; Oguejiofor CB; Chigbo CG; Ogabido CA; Okafor CC; Okafor CG
    J Int Med Res; 2023 May; 51(5):3000605231171489. PubMed ID: 37165643
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A randomised controlled trial of oral zinc sulphate for primary dysmenorrhoea in adolescent females.
    Zekavat OR; Karimi MY; Amanat A; Alipour F
    Aust N Z J Obstet Gynaecol; 2015 Aug; 55(4):369-73. PubMed ID: 26132140
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of the effect of ginger and zinc sulfate on primary dysmenorrhea: a placebo-controlled randomized trial.
    Kashefi F; Khajehei M; Tabatabaeichehr M; Alavinia M; Asili J
    Pain Manag Nurs; 2014 Dec; 15(4):826-33. PubMed ID: 24559600
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A randomised placebo-controlled trial of a traditional Chinese herbal formula in the treatment of primary dysmenorrhoea.
    Yeh LL; Liu JY; Lin KS; Liu YS; Chiou JM; Liang KY; Tsai TF; Wang LH; Chen CT; Huang CY
    PLoS One; 2007 Aug; 2(8):e719. PubMed ID: 17710126
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Herbal and dietary therapies for primary and secondary dysmenorrhoea.
    Proctor ML; Murphy PA
    Cochrane Database Syst Rev; 2001; (3):CD002124. PubMed ID: 11687013
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acupuncture for dysmenorrhoea.
    Smith CA; Armour M; Zhu X; Li X; Lu ZY; Song J
    Cochrane Database Syst Rev; 2016 Apr; 4(4):CD007854. PubMed ID: 27087494
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acupuncture point injection treatment of primary dysmenorrhoea: a randomised, double blind, controlled study.
    Wade C; Wang L; Zhao WJ; Cardini F; Kronenberg F; Gui SQ; Ying Z; Zhao NQ; Chao MT; Yu J
    BMJ Open; 2016 Jan; 6(1):e008166. PubMed ID: 26733563
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transcutaneous electrical nerve stimulation and acupuncture for primary dysmenorrhoea.
    Proctor ML; Smith CA; Farquhar CM; Stones RW
    Cochrane Database Syst Rev; 2002; 2002(1):CD002123. PubMed ID: 11869624
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Once daily oral relugolix combination therapy versus placebo in patients with endometriosis-associated pain: two replicate phase 3, randomised, double-blind, studies (SPIRIT 1 and 2).
    Giudice LC; As-Sanie S; Arjona Ferreira JC; Becker CM; Abrao MS; Lessey BA; Brown E; Dynowski K; Wilk K; Li Y; Mathur V; Warsi QA; Wagman RB; Johnson NP
    Lancet; 2022 Jun; 399(10343):2267-2279. PubMed ID: 35717987
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A randomized double-blind, placebo-controlled trial of zinc sulfate supplementation for alleviation of radiation-induced oral mucositis and pharyngitis in head and neck cancer patients.
    Sangthawan D; Phungrassami T; Sinkitjarurnchai W
    J Med Assoc Thai; 2013 Jan; 96(1):69-76. PubMed ID: 23720981
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oral contraceptives for pain associated with endometriosis.
    Brown J; Crawford TJ; Datta S; Prentice A
    Cochrane Database Syst Rev; 2018 May; 5(5):CD001019. PubMed ID: 29786828
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A double-blind, randomised, crossover study of two doses of a single-tablet combination of ibuprofen/paracetamol and placebo for primary dysmenorrhoea.
    Eccles R; Holbrook A; Jawad M
    Curr Med Res Opin; 2010 Nov; 26(11):2689-99. PubMed ID: 20942614
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nifedipine for primary dysmenorrhoea.
    Earl RA; Grivell RM
    Cochrane Database Syst Rev; 2021 Dec; 12(12):CD012912. PubMed ID: 34921554
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of zinc sulfate supplement on febrile seizure recurrence prevention in children with normal serum zinc level: A randomised clinical trial.
    Fallah R; Sabbaghzadegan S; Karbasi SA; Binesh F
    Nutrition; 2015; 31(11-12):1358-61. PubMed ID: 26429655
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A randomised controlled trial of vitamin E in the treatment of primary dysmenorrhoea.
    Ziaei S; Zakeri M; Kazemnejad A
    BJOG; 2005 Apr; 112(4):466-9. PubMed ID: 15777446
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gabapentin for chronic pelvic pain in women (GaPP2): a multicentre, randomised, double-blind, placebo-controlled trial.
    Horne AW; Vincent K; Hewitt CA; Middleton LJ; Koscielniak M; Szubert W; Doust AM; Daniels JP;
    Lancet; 2020 Sep; 396(10255):909-917. PubMed ID: 32979978
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combined oral contraceptive pill (OCP) as treatment for primary dysmenorrhoea.
    Proctor ML; Roberts H; Farquhar CM
    Cochrane Database Syst Rev; 2001; (4):CD002120. PubMed ID: 11687142
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of zinc supplementation on markers of insulin resistance and lipid profiles in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial.
    Foroozanfard F; Jamilian M; Jafari Z; Khassaf A; Hosseini A; Khorammian H; Asemi Z
    Exp Clin Endocrinol Diabetes; 2015 Apr; 123(4):215-20. PubMed ID: 25868059
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Comparative efficacy and tolerability of drotaverine 80 mg and ibuprofen 400 mg in patients with primary dysmenorrhoea--protocol DOROTA].
    Debski R; Niemiec T; Mazurek M; Debska M
    Ginekol Pol; 2007 Dec; 78(12):933-8. PubMed ID: 18411915
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.